Texas Permanent School Fund Corp lessened its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 17.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,665 shares of the medical research company's stock after selling 8,887 shares during the

RadNet, Inc. (NASDAQ: RDNT) stock is trading lower on Tuesday. Hunterbrook Capital released a short report on Tuesday on the company, stating that the smaller companies are slapping "AI" on their pitch decks and watching their valuations soar.

Castleark Management LLC increased its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 241.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,203 shares of the medical research company's stock after buying an additional 68,050 shares

Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Breast Suite, 2 a first-of-its-kind end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive new suite of solutions.

CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health.

Creative Planning raised its stake in shares of RadNet, Inc. (NASDAQ: RDNT) by 76.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 24,592 shares of the medical research company's stock after buying an additional 10,637 shares during the quarter. Creative Planning's

Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in RadNet, Inc. (NASDAQ: RDNT) by 8.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,952 shares of the medical research company's stock after purchasing an additional 1,363 shares during

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities

Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care